ROBERT J HUGIN
CIK 1232505 · see remarks · last filed 2026-05-26
ROBERT J HUGIN is a corporate insider who has filed 117 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for CB, was dated May 26, 2026. Across all open-market trades the lifetime net is −$160.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$7.32M
9
117
-$160.24M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CB | Director | 21,851 | $328.14 | $7.17M | $0 | 7 | 2026-05-26 |
| BHVN | Director | 12,959 | $11.28 | $146.2K | $0 | 9 | 2025-05-07 |
| Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted | Director | 0 | — | — | $0 | 1 | 2022-10-03 |
| Allergan plc (AGN) Delisted | Director | 0 | — | — | $0 | 4 | 2020-05-11 |
| MEDICINES CO /DE (MDCO) Delisted | Director | 163,431 | — | — | $0 | 16 | 2017-11-13 |
| CELGENE CORP /DE/ (CELGZ) Delisted | see remarks | 1,069,706 | — | — | -$70.81M | 50 | 2017-10-31 |
| DANAHER CORP /DE/ (DHRw) Delisted | Director | 3,576 | — | — | $0 | 3 | 2017-05-17 |
| CELGENE CORP /DE/ (CELG) Delisted | Chief Executive Officer | 735,014 | — | — | -$89.43M | 24 | 2010-10-14 |
| Coley Pharmaceutical Group, Inc. (COLY) Delisted | Director | — | — | — | $0 | 1 | 2007-06-15 |
Recent Filings
117 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-26 | CB | Grant (A) | +1,135 | $0 | EDGAR |
| 2025-05-16 | CB | Grant (A) | +1,284 | $0 | EDGAR |
| 2025-05-07 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2024-05-17 | CB | Grant (A) | +1,227 | $0 | EDGAR |
| 2024-05-02 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | CB | Grant (A) | +1,634 | $0 | EDGAR |
| 2023-05-04 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2022-10-12 | BHVN | Tax (F) | −12,959 | -$97.2K | EDGAR |
| 2022-10-05 | — | Mixed | +19,486 | $48.9K | |
| 2022-10-03 | Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted | Disp (D) | −2,900 | -$430.6K | EDGAR |